-+ 0.00%
-+ 0.00%
-+ 0.00%
Kefu Healthcare (301087.SZ) plans to acquire 60% of Kangjuren's shares for 99.48 million yuan to improve the layout of the respiratory support sector
Share
Listen to the news

According to Zhitong Finance App, Kefu Healthcare (301087.SZ) announced that the company plans to acquire 60% of the shares of Hefei Kangjuren Medical Device Technology Co., Ltd. (“Kangjuren”) with its own capital of 99.48 million yuan. After the transaction is completed, Kang Juren will become a holding subsidiary of the company and will be included in the scope of the company's consolidated statements. The target company is engaged in R&D, production, sales and service of medical devices such as oxygen concentrators and nebulizers.

The acquisition of 60% of the shares in the target company will help the company improve the layout of the respiratory support sector, positively help the company expand the market share of oxygen concentrators and consolidate the company's market position in the field of respiratory health, and can also effectively expand the production capacity of the company's oxygen concentrator product line. The target company's business is mainly online channels and ODM business. The company can rely on its own brand influence, online and offline integration channels, and overseas sales networks to improve the target company's product structure and profit level.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending